Analysis of platelets treated with Mirasol® Pathogen Reduction Technology and stored in platelet additive solution (PAS)

被引：0
|
作者：
Marschner, S.
Cardigan, R. [2 ]
Cookson, P. [3 ]
de Korte, Dirk [4 ]
Dumont, Larry J. [5 ]
Einarson, M. [6 ]
Herschel, L. [5 ]
Janetzko, K.
Vassallo, R. [1 ]
Goodrich, R. [1 ]
机构：
[1] LLC, Navigant Biotechnol, Lakewood, CO USA
[2] NHS Blood & Transplant, Cambridge, England
[3] NHSBT, Brentwood, Essex, England
[4] Sanquin Blood Bank Reg N W, Amsterdam, Netherlands
[5] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[6] Amer Red Cross, Blood Serv, Philadelphia, PA USA
来源：
TRANSFUSION | 2008年 / 48卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148A / 148A
页数：1
相关论文
共 50 条
  • [1] The Mirasol® Pathogen Reduction Technology system and quality of platelets stored in platelet additive solution
    Reikvam, Hakon
    Marschner, Susanne
    Apelseth, Torunn Oveland
    Goodrich, Ray
    Hervig, Tor
    [J]. BLOOD TRANSFUSION, 2010, 8 (03) : 186 - 192
  • [2] Analysis of cell quality of platelet hyperconcentrates treated with MIRASOL® pathogen reduction technology and stored in PAS
    Marschner, S.
    Einarson, M.
    Vassallo, R.
    Goodrich, R.
    [J]. VOX SANGUINIS, 2008, 95 : 265 - 265
  • [3] Preparation of buffy coat platelet hyperconcentrates treated with Mirasol® Pathogen Reduction Technology and stored in PAS
    de Korte, Dirk
    Marschner, S.
    Gouwerok, E.
    Vlaar, R.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 154A - 154A
  • [4] Generation of double buffy coat platelet hyperconcentrates treated with mirasol? Pathogen reduction technology and stored in PAS
    de Korte, D.
    [J]. VOX SANGUINIS, 2008, 95 : 278 - 278
  • [5] Treatment of Buffy Coat Platelets in Platelet Additive Solution with the Mirasol® Pathogen Reduction Technology System
    Castrillo, Azucena
    Cardoso, Marcia
    Rouse, Lindsay
    [J]. TRANSFUSION MEDICINE AND HEMOTHERAPY, 2013, 40 (01) : 44 - 48
  • [6] Hemostatic Function of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 97A - 98A
  • [7] In Vivo Recovery of Platelets Treated with Pathogen Reduction Technology Stored in Platelet Additive Solutions
    Drawz, S. M.
    Marschner, S.
    Yanez, M.
    Garcia de Coca, A.
    Coene, J.
    [J]. TRANSFUSION, 2014, 54 : 40A - 41A
  • [8] In Vitro Cell Quality Tests of Buffy Coat Platelets in Additive Solution Treated with Mirasol Pathogen Reduction Technology
    Ostrowski, S. R.
    Bochsen, L.
    Salado-Jimena, J. A.
    Ullum, H.
    Reynaerts, I.
    Goodrich, R. P.
    Johansson, P. I.
    [J]. TRANSFUSION, 2009, 49 : 93A - 94A
  • [9] The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover
    Johnson, L.
    Winter, K. M.
    Reid, S.
    Hartkopf-Theis, T.
    Marschner, S.
    Goodrich, R. P.
    Marks, D. C.
    [J]. VOX SANGUINIS, 2011, 101 (03) : 208 - 214
  • [10] Platelet Refractoriness Attributed to Platelets Stored in Platelet Additive Solution (PAS)
    Cooling, Laura
    Li, Sean
    Downs, Theresa
    Hoffmann, Sandra
    Davenport, Robertson
    [J]. TRANSFUSION, 2021, 61 : 241A - 242A
12345